Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index; 30 of the 64 sources its claims cite were checked for support.

Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation

Open access

Abstract

Decellularized extracellular matrix scaffold, widely utilized for organ engineering, often undergoes matrix decomposition after transplantation and produces byproducts that cause inflammation, leading to clinical failure. Here we propose a strategy using nano-graphene oxide to modify the biophysical properties of decellularized liver scaffolds. Notably, we demonstrate that scaffolds crosslinked with nano-graphene oxide show high resistance to enzymatic degradation via direct inhibition of matrix metalloproteinase activity and increased mechanical rigidity. We find that M2-like macrophage polarization is promoted within the crosslinked scaffolds, which reduces graft-elicited inflammation. Moreover, we show that low activities of matrix metalloproteinases, attributed to both nano-graphene oxide and tissue inhibitors of metalloproteinases expressed by M2c, can protect the crosslinked scaffolds against in vivo degradation. Lastly, we demonstrate that bioengineered livers fabricated with the crosslinked scaffolds remain functional, thereby effectively regenerating damaged livers after transplantation into liver failure mouse models. Overall, nano-graphene oxide crosslinking prolongs allograft survival and ultimately improves therapeutic effects of bioengineered livers, which offer an alternative for donor organs.

Overview

CoChat Summary

## TL;DR

Nano-graphene oxide (NGO) was used to crosslink decellularized liver scaffolds, making them mechanically stronger and more resistant to MMP-mediated degradation while also shifting the immune response toward M2c-like macrophages. In mouse transplantation models, NGO-crosslinked bioengineered livers remained more functional and supported better liver regeneration than non-crosslinked controls.

## Key findings

  • NGO crosslinking improved scaffold chemistry and mechanics: the NGO-5 and NGO-10 scaffolds had increased crosslinking degree, Young’s modulus comparable to glutaraldehyde, and higher ultimate tensile strength than control scaffolds.
  • NGO-crosslinked scaffolds were more resistant to enzymatic degradation: after MMP treatment, NGO-5 and NGO-10 retained scaffold structure and insoluble collagen better than controls, with lower weight loss and preserved microstructure.
  • NGOs directly inhibited MMP activity: NMR showed direct interactions with MMP-1, MMP-2, and MMP-9, and NGO reduced catalytic activity in a dose-dependent manner, including in the presence of serum proteins.
  • In vivo, NGO scaffolds reduced inflammation and lasted longer: by day 60, NGO-5 and NGO-10 scaffolds remained highly stable, while control and NGO-1 scaffolds were completely absorbed; NGO groups also showed reduced neutrophil infiltration, lower systemic cytokines, and more M2/M2c-like macrophages and Treg cells.
  • In bioengineered livers, NGO-MBLs showed better function and regeneration: in acute and chronic liver failure models, NGO-MBLs retained more scaffold and hepatocyte-like cells, had lower MMP-2/MMP-9 and higher TIMP-1, reduced serum ALT/AST, and less fibrosis than CTL-MBLs.

## Methods

  • Decellularized rat liver scaffolds were produced by perfusion decellularization, then crosslinked by perfusing PBS, 0.625% glutaraldehyde, or NGOs at 1, 5, or 10 μg/mL through the bile duct and portal vein for 24 h at 4 °C.
  • Scaffold characterization included SEM, HRTEM, Raman, ATR-FTIR, zeta potential, swelling ratio, ninhydrin assay, tensile testing, and LC/MS-based matrisome analysis; MMP resistance was tested in vitro using active MMP-1, MMP-2, and MMP-9.
  • In vivo testing used subcutaneous implantation in 6-week-old male BALB/c mice, hPBMC-derived macrophage polarization assays, biocompatibility assays with hCdHs and ECs, and transplantation of mouse bioengineered livers into acute (70% PHx) and chronic (TAA-induced) liver failure mouse models.

## Limitations

  • The paper states that more kinds of liver-composing cells should be included in future bioengineered livers, specifically biliary epithelial cells, Kupffer cells, and hepatic stellate cells.
  • The paper states that protocol optimization is still needed for injected cell types, total cell number, mixing ratio, and ex vivo culture duration.
  • The paper states that human-scale clinical translation remains unresolved and that porcine scaffolds should be tested before scaling up; it also notes the need for longer-term monitoring of immune profiles and possible tumorigenic risks.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1038/s41467-023-35941-2

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 NGO crosslinking contributes to improvement of physical properties of decellularized scaffolds via amide bond formation. a Scanning electron microscopy (SEM) analysis and macroscopic images of the scaffolds crosslinked with PBS (CTL), 0.625% glutaraldehyde (GA), and nano-graphene oxide (NGO): 1 μg/mL (NGO-1), 5 μg/mL (NGO-5) and 10 μg/mL (NGO-10). Note the NGOs attached to the surface of extracellular matrix (ECM) fibrils (yellow arrow). Scale bar, 1 µm. b Representative confocal images of the NGO-crosslinked scaffolds probed with streptavidin (green), Collagen type I and type IV, respectively (red). The scaffolds crosslinked with 10 μg/mL of non-biotinylated NGOs were used as negative control. Scale bar, 200 µm. c Overlap coefficient measuring the degree of colocalization between Streptavidin+ NGOs and Collagen I+ or Collagen IV+ ECM fibers (n = 4). d Raman spectroscopy analysis of CTL scaffold and NGO-crosslinked scaffolds. e Fourier transform infrared spectroscopy (FTIR) transmittance spectra of CTL scaffold and the scaffold crosslinked with NGO-5. f Ninhydrin assay for quantifying the free amine groups of scaffolds in each group (n = 4). g Schematic illustration of chemical crosslinking decellularized ECM scaffolds with NGOs. h Young’s modulus of each scaffold in 5% strain (n = 4). i Maximum amount of stress that each scaffold could withstand (n = 4). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 1 NGO crosslinking contributes to improvement of physical properties of decellularized scaffolds via amide bond formation. a Scanning electron microscopy (SEM) analysis and macroscopic images of the scaffolds crosslinked with PBS (CTL), 0.625% glutaraldehyde (GA), and nano-graphene oxide (NGO): 1 μg/mL (NGO-1), 5 μg/mL (NGO-5) and 10 μg/mL (NGO-10). Note the NGOs attached to the surface of extracellular matrix (ECM) fibrils (yellow arrow). Scale bar, 1 µm. b Representative confocal images of the NGO-crosslinked scaffolds probed with streptavidin (green), Collagen type I and type IV, respectively (red). The scaffolds crosslinked with 10 μg/mL of non-biotinylated NGOs were used as negative control. Scale bar, 200 µm. c Overlap coefficient measuring the degree of colocalization between Streptavidin+ NGOs and Collagen I+ or Collagen IV+ ECM fibers (n = 4). d Raman spectroscopy analysis of CTL scaffold and NGO-crosslinked scaffolds. e Fourier transform infrared spectroscopy (FTIR) transmittance spectra of CTL scaffold and the scaffold crosslinked with NGO-5. f Ninhydrin assay for quantifying the free amine groups of scaffolds in each group (n = 4). g Schematic illustration of chemical crosslinking decellularized ECM scaffolds with NGOs. h Young’s modulus of each scaffold in 5% strain (n = 4). i Maximum amount of stress that each scaffold could withstand (n = 4). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 2 In vitro resistance of NGO-crosslinked scaffolds to enzymatic degradation. a Raman spectra of scaffold crosslinked with 5 μg/mL nano-graphene oxide (NGO-5) after MMP-1 treatment (top) and degradation products of MMP-treated scaffold (bottom). b,c Fourier transform infrared spectroscopy (FTIR) spectra of non-crosslinked scaffolds (CTL) and NGO-5 scaffolds were measured before (black) and after (red) MMP-1 treatment. d Scanning electron microscopy (SEM) images of the crosslinked scaffolds after MMP-1 treatment for 2 h. Scale bar, 1 µm. e Picrosirius red staining of the scaffolds degraded by MMP-1. Scale bar, 200 µm. f Area quantification of collagen fibers stained by picrosirius red (n = 4). g Weight loss measurements of each scaffold after treatment of MMP-1, MMP-2 and MMP-9 (n = 4). h Ninhydrin assay quantifying the crosslinking degree of the scaffolds after MMP treatment (n = 4). i Quantification of the amount of retained insoluble collagen of the scaffolds exposed to MMPs normalized to that of intact scaffolds (n = 4). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 2 In vitro resistance of NGO-crosslinked scaffolds to enzymatic degradation. a Raman spectra of scaffold crosslinked with 5 μg/mL nano-graphene oxide (NGO-5) after MMP-1 treatment (top) and degradation products of MMP-treated scaffold (bottom). b,c Fourier transform infrared spectroscopy (FTIR) spectra of non-crosslinked scaffolds (CTL) and NGO-5 scaffolds were measured before (black) and after (red) MMP-1 treatment. d Scanning electron microscopy (SEM) images of the crosslinked scaffolds after MMP-1 treatment for 2 h. Scale bar, 1 µm. e Picrosirius red staining of the scaffolds degraded by MMP-1. Scale bar, 200 µm. f Area quantification of collagen fibers stained by picrosirius red (n = 4). g Weight loss measurements of each scaffold after treatment of MMP-1, MMP-2 and MMP-9 (n = 4). h Ninhydrin assay quantifying the crosslinking degree of the scaffolds after MMP treatment (n = 4). i Quantification of the amount of retained insoluble collagen of the scaffolds exposed to MMPs normalized to that of intact scaffolds (n = 4). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 3 NGOs suppress MMP activities via direct binding to catalytic domain of MMPs. a, b 1H nuclear magnetic resonance (NMR) spectra. Nano-graphene oxide (NGO) only, MMPs only (MMP-1, MMP-9) and MMPs incubated with NGOs (MMP + NGO). c Saturation transfer difference (STD)-NMR spectra of MMP-1, MMP-2 and MMP-9 in the presence of NGOs (red) and the respective reference spectra (black). d–f Catalytic activities of MMP-1, MMP-2 and MMP-9 incubated with 1 μg/mL, 5 μg/mL and 10 μg/mL of NGOs dispersed in distilled water (d), immobilized within the scaffolds (e), or incubated with serum proteins (f). Vehicle (distilled water) and inhibitors (1,10-Phenanthroline for MMP-1 inhibition and doxycycline for MMP-2 and MMP-9 inhibition) were used (n = 4). g Zinc chelating activity of NGOs at different doses. 10 µM of EDTA was used for a positive control (n = 4). h, i 1H NMR spectra of NGO only, glutamate/ histidine only, and glutamate/ histidine incubated with NGOs (glutamate/ histidine + NGO). j Graphical scheme of interactions between MMPs and NGOs. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001, ns; not statistically significant versus Vehicle). Source data are provided as a Source Data file.
Fig. 3 NGOs suppress MMP activities via direct binding to catalytic domain of MMPs. a, b 1H nuclear magnetic resonance (NMR) spectra. Nano-graphene oxide (NGO) only, MMPs only (MMP-1, MMP-9) and MMPs incubated with NGOs (MMP + NGO). c Saturation transfer difference (STD)-NMR spectra of MMP-1, MMP-2 and MMP-9 in the presence of NGOs (red) and the respective reference spectra (black). d–f Catalytic activities of MMP-1, MMP-2 and MMP-9 incubated with 1 μg/mL, 5 μg/mL and 10 μg/mL of NGOs dispersed in distilled water (d), immobilized within the scaffolds (e), or incubated with serum proteins (f). Vehicle (distilled water) and inhibitors (1,10-Phenanthroline for MMP-1 inhibition and doxycycline for MMP-2 and MMP-9 inhibition) were used (n = 4). g Zinc chelating activity of NGOs at different doses. 10 µM of EDTA was used for a positive control (n = 4). h, i 1H NMR spectra of NGO only, glutamate/ histidine only, and glutamate/ histidine incubated with NGOs (glutamate/ histidine + NGO). j Graphical scheme of interactions between MMPs and NGOs. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001, ns; not statistically significant versus Vehicle). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 4 Constructive remodeling of NGO-crosslinked scaffolds by M2c macrophages. Gross images (a) of harvested scaffolds and the box plot (b) showing cross-sectional area of harvested scaffolds after 35 days of transplantation. In each box plot, the center line within the box indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate outliers outside the 10th and 90th percentile (n = 5). Representative confocal images of the implants on day 35 in each group stained with the following antibodies; DAPI (blue), F4/80 (red), MMP-9 (green) and CCR7 (white) (c), and TIMP-1 (green) and CD206 (white) (d). Scale bar, 400 µm. e Quantification of infiltrating M1 and M2 macrophages normalized to F4/80+ cells within the implants (n = 5). f Ratio of M1+ cells to M2+ cells in each group (n = 5). qRT-PCR of M1 (g), M2 (h), and M2c (i) -related genes in each scaffold harvested on day 35. (n = 5) j Mean fluorescence intensity (MFI) of MMP-9 and TIMP-1 in the stained sections of each group (n = 5). qRT-PCR analysis of mouse Timp subtypes (k) and Mmp subtypes (l) in each scaffold harvested on day 35 (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL. ###p < 0.001 versus GA. ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 4 Constructive remodeling of NGO-crosslinked scaffolds by M2c macrophages. Gross images (a) of harvested scaffolds and the box plot (b) showing cross-sectional area of harvested scaffolds after 35 days of transplantation. In each box plot, the center line within the box indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate outliers outside the 10th and 90th percentile (n = 5). Representative confocal images of the implants on day 35 in each group stained with the following antibodies; DAPI (blue), F4/80 (red), MMP-9 (green) and CCR7 (white) (c), and TIMP-1 (green) and CD206 (white) (d). Scale bar, 400 µm. e Quantification of infiltrating M1 and M2 macrophages normalized to F4/80+ cells within the implants (n = 5). f Ratio of M1+ cells to M2+ cells in each group (n = 5). qRT-PCR of M1 (g), M2 (h), and M2c (i) -related genes in each scaffold harvested on day 35. (n = 5) j Mean fluorescence intensity (MFI) of MMP-9 and TIMP-1 in the stained sections of each group (n = 5). qRT-PCR analysis of mouse Timp subtypes (k) and Mmp subtypes (l) in each scaffold harvested on day 35 (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL. ###p < 0.001 versus GA. ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 5 Ex vivo macrophage polarization from hPBMCs within NGO-crosslinked scaffolds. a Schematic diagram of ex vivo macrophage differentiation from human CD14+ monocytes within scaffolds crosslinked with nano-graphene oxide (NGO). Flow cytometry analysis of M1 (b) and M2c (c) expression within CD14+ populations in each group (n = 4). d Representative confocal images of M1 (CCR7, CD86: green, CD68: red, DAPI: blue). Scale bar, 100 µm. e Quantification of M1 normalized to CD68+ cells (n = 4). f Representative confocal images of M2 (CD206, CD163: green, CD68: red, DAPI: blue). Scale bar, 100 µm. g Quantification of M2 normalized to CD68+ cells (n = 4). Magnified confocal images of the non-crosslinked scaffolds (CTL) (h) and crosslinked scaffolds with 5 μg/mL of NGOs (NGO-5) (i), Probed with CD206 (red), DAPI (blue) and following primary antibodies: MMP-1, MMP-2, MMP-9 and TIMP-1 (green). Scale bar, 40 µm. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (**p < 0.01, ***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 5 Ex vivo macrophage polarization from hPBMCs within NGO-crosslinked scaffolds. a Schematic diagram of ex vivo macrophage differentiation from human CD14+ monocytes within scaffolds crosslinked with nano-graphene oxide (NGO). Flow cytometry analysis of M1 (b) and M2c (c) expression within CD14+ populations in each group (n = 4). d Representative confocal images of M1 (CCR7, CD86: green, CD68: red, DAPI: blue). Scale bar, 100 µm. e Quantification of M1 normalized to CD68+ cells (n = 4). f Representative confocal images of M2 (CD206, CD163: green, CD68: red, DAPI: blue). Scale bar, 100 µm. g Quantification of M2 normalized to CD68+ cells (n = 4). Magnified confocal images of the non-crosslinked scaffolds (CTL) (h) and crosslinked scaffolds with 5 μg/mL of NGOs (NGO-5) (i), Probed with CD206 (red), DAPI (blue) and following primary antibodies: MMP-1, MMP-2, MMP-9 and TIMP-1 (green). Scale bar, 40 µm. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (**p < 0.01, ***p < 0.001 versus CTL, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 6 Evaluation of NGO-crosslinked scaffolds on day 60 after transplantation. Gross images (a) and the box plot (b) showing cross-sectional area of scaffold remnants harvested on day 60 in each group. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). c H&E staining of scaffold remnants on day 60 in each group (I: Implanted scaffolds, S: Surrounding tissues) and magnified images. Scale bar, 200 µm. d Representative confocal images of the implants probed with neutrophil (red) and DAPI (blue). Scale bar, 100 µm. e Quantification of infiltrating neutrophils in each group (n = 5). f Global cytokine analysis of the serum samples collected from the mice receiving each implant and sham mice on day 60, and quantification of pixel density of the spots corresponding to IL-1a, IL-16, M-CSF and TNF-α (n = 2). g Immunofluorescence analysis of the implants harvested on day 60. M1 (CCR7, iNOS; red), M2 (CD206, CD163; red) markers, pan-macrophage marker (F4/80; green), and DAPI (blue). Scale bar, 200 µm. h Quantification of detected M1 and M2 macrophages normalized to F4/80+ cells (n = 5). i Ratio of M1+ cells to M2+ cells within the implants (n = 5). qRT-PCR analysis of M1 (j) and M2c (k) -related genes in each group on day 60 (n = 3). l Schematic diagram of pivotal roles of nano-graphene oxide (NGO) in the events following transplantation of decellularized extracellular matrix (dECM) scaffolds. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (***p < 0.001 versus CTL, ##p < 0.01, ###p < 0.001 versus GA, $$$p < 0.001, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 6 Evaluation of NGO-crosslinked scaffolds on day 60 after transplantation. Gross images (a) and the box plot (b) showing cross-sectional area of scaffold remnants harvested on day 60 in each group. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). c H&E staining of scaffold remnants on day 60 in each group (I: Implanted scaffolds, S: Surrounding tissues) and magnified images. Scale bar, 200 µm. d Representative confocal images of the implants probed with neutrophil (red) and DAPI (blue). Scale bar, 100 µm. e Quantification of infiltrating neutrophils in each group (n = 5). f Global cytokine analysis of the serum samples collected from the mice receiving each implant and sham mice on day 60, and quantification of pixel density of the spots corresponding to IL-1a, IL-16, M-CSF and TNF-α (n = 2). g Immunofluorescence analysis of the implants harvested on day 60. M1 (CCR7, iNOS; red), M2 (CD206, CD163; red) markers, pan-macrophage marker (F4/80; green), and DAPI (blue). Scale bar, 200 µm. h Quantification of detected M1 and M2 macrophages normalized to F4/80+ cells (n = 5). i Ratio of M1+ cells to M2+ cells within the implants (n = 5). qRT-PCR analysis of M1 (j) and M2c (k) -related genes in each group on day 60 (n = 3). l Schematic diagram of pivotal roles of nano-graphene oxide (NGO) in the events following transplantation of decellularized extracellular matrix (dECM) scaffolds. Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (***p < 0.001 versus CTL, ##p < 0.01, ###p < 0.001 versus GA, $$$p < 0.001, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 7 Transplantation of MBLs into a mouse model of acute liver failure. a Immunostaining of normal mouse livers and mouse bioengineered livers (MBLs) fabricated using scaffolds without crosslinking (CTL-MBLs), crosslinked with glutaraldehyde (GA-MBLs), and crosslinked with nano-graphene oxide (NGO-MBLs). ALB (green) and DAPI (nuclei, blue). Scale bar, 100 µm. b Quantification of ALB+ cells (n = 4). c Immunostaining of CD31 (green) and DAPI (nuclei, blue). Scale bar, 100 µm. d Quantification of CD31+ cells covering vascular lumen (n = 4). Quantification of secreted albumin (e) and urea (f) from CTL-MBLs, NGO-MBLs and GA-MBLs during bioreactor culture on day 4 and 8 (n = 4). g Schematic diagram of transplantation of MBLs into the mice receiving 70% partial hepatectomy. h Gross images of transplanted CTL-MBLs and NGO-MBLs on day 5. i Residual amounts of transplanted CTL-MBLs and NGO-MBLs, characterized by cross-sectional area and weight of transplants (n = 5). j Immunostaining of harvested CTL-MBLs and NGO-MBLs probed with following antibodies: F4/80 (red), DAPI (blue), MMP-9 (green) and CCR7 (white), TIMP-1 (green) and CD206 (white), streptavidin (green) and MMP-2 (red). Scale bar, 100 µm. Quantification of M1 macrophages and M2 macrophages normalized to F4/80+ cells (k), and MMP-2 expression (l) within CTL-MBLs and NGO-MBLs (n = 5). m Cytometric bead array of serum samples from the following groups; Normal mice, the mice receiving partial hepatectomy (PHx Sham), the mice receiving CTL-MBL and NGO-MBL transplantation after PHx. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). n Transplanted CTL-MBLs and NGO-MBLs stained with ALB (green) and HNF4α (red). Scale bar, 100 µm. o qRT-PCR analysis of liver regeneration-related genes (n = 5). p Serum levels of ALT and AST in each mouse on day 5 (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (b, d–f, m, o, p) and unpaired, two-tailed student’s t test (i, k, l) (*p < 0.05, **p < 0.01, ***p < 0.001, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 7 Transplantation of MBLs into a mouse model of acute liver failure. a Immunostaining of normal mouse livers and mouse bioengineered livers (MBLs) fabricated using scaffolds without crosslinking (CTL-MBLs), crosslinked with glutaraldehyde (GA-MBLs), and crosslinked with nano-graphene oxide (NGO-MBLs). ALB (green) and DAPI (nuclei, blue). Scale bar, 100 µm. b Quantification of ALB+ cells (n = 4). c Immunostaining of CD31 (green) and DAPI (nuclei, blue). Scale bar, 100 µm. d Quantification of CD31+ cells covering vascular lumen (n = 4). Quantification of secreted albumin (e) and urea (f) from CTL-MBLs, NGO-MBLs and GA-MBLs during bioreactor culture on day 4 and 8 (n = 4). g Schematic diagram of transplantation of MBLs into the mice receiving 70% partial hepatectomy. h Gross images of transplanted CTL-MBLs and NGO-MBLs on day 5. i Residual amounts of transplanted CTL-MBLs and NGO-MBLs, characterized by cross-sectional area and weight of transplants (n = 5). j Immunostaining of harvested CTL-MBLs and NGO-MBLs probed with following antibodies: F4/80 (red), DAPI (blue), MMP-9 (green) and CCR7 (white), TIMP-1 (green) and CD206 (white), streptavidin (green) and MMP-2 (red). Scale bar, 100 µm. Quantification of M1 macrophages and M2 macrophages normalized to F4/80+ cells (k), and MMP-2 expression (l) within CTL-MBLs and NGO-MBLs (n = 5). m Cytometric bead array of serum samples from the following groups; Normal mice, the mice receiving partial hepatectomy (PHx Sham), the mice receiving CTL-MBL and NGO-MBL transplantation after PHx. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). n Transplanted CTL-MBLs and NGO-MBLs stained with ALB (green) and HNF4α (red). Scale bar, 100 µm. o qRT-PCR analysis of liver regeneration-related genes (n = 5). p Serum levels of ALT and AST in each mouse on day 5 (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by ordinary one-way ANOVA with post-hoc Tukey test (b, d–f, m, o, p) and unpaired, two-tailed student’s t test (i, k, l) (*p < 0.05, **p < 0.01, ***p < 0.001, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central
Fig. 8 Transplantation of MBLs into a mouse model of chronic liver failure. a Schematic diagram of the strategy for establishing thioacetamide (TAA)-induced chronic liver failure model and subsequent transplantation of mouse bioengineered livers produced by using scaffolds without crosslinking (CTL-MBLs) and crosslinked with nano-graphene oxide (NGO-MBLs). b Gross images of remaining CTL-MBLs and NGO-MBLs at 2 weeks after transplantation. c The residual amounts of CTL-MBLs and NGO-MBLs, characterized by cross-sectional area and weight of residual transplants (n = 5). d Immunostaining of harvested CTL-MBLs and NGO-MBLs probed with following antibodies: F4/80 (red), DAPI (blue), MMP-9 (green) and CCR7 (white), TIMP-1 (green) and CD206 (white), and streptavidin (green) and MMP-2 (red). Scale bar, 100 µm. Quantification of M1 macrophages and M2 macrophages normalized to F4/80+ cells (e), and MMP-2 expression (f) in each group (n = 5). g Cytometric bead array performed with the serum collected at 2 weeks from the normal mice, the mice in which chronic liver injury was induced (Sham), the mice receiving CTL-MBL and NGO-MBL transplantation. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). h Immunostaining of harvested CTL-MBLs and NGO-MBLs. ALB (green), HNF4α (red) and DAPI (blue). Scale bar, 100 µm. Picrosirius red staining (i) of livers in each group and quantification (j) of fibrotic area. Scale bar, 40 µm (n = 5). k qRT-PCR analysis of liver fibrosis-related genes in each group (n = 5). Serum ALT (l) and AST (m) levels of mice in each group, before and after transplantation (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by unpaired, two-tailed student’s t test (c, e, f), Ordinary one-way ANOVA with post-hoc Tukey test (g, j, k) and two-way ANOVA with post-hoc Tukey test (l, m) (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL-MBL, ##p < 0.05, ###p < 0.001 versus Sham, ns; not statistically significant). Source data are provided as a Source Data file.
Fig. 8 Transplantation of MBLs into a mouse model of chronic liver failure. a Schematic diagram of the strategy for establishing thioacetamide (TAA)-induced chronic liver failure model and subsequent transplantation of mouse bioengineered livers produced by using scaffolds without crosslinking (CTL-MBLs) and crosslinked with nano-graphene oxide (NGO-MBLs). b Gross images of remaining CTL-MBLs and NGO-MBLs at 2 weeks after transplantation. c The residual amounts of CTL-MBLs and NGO-MBLs, characterized by cross-sectional area and weight of residual transplants (n = 5). d Immunostaining of harvested CTL-MBLs and NGO-MBLs probed with following antibodies: F4/80 (red), DAPI (blue), MMP-9 (green) and CCR7 (white), TIMP-1 (green) and CD206 (white), and streptavidin (green) and MMP-2 (red). Scale bar, 100 µm. Quantification of M1 macrophages and M2 macrophages normalized to F4/80+ cells (e), and MMP-2 expression (f) in each group (n = 5). g Cytometric bead array performed with the serum collected at 2 weeks from the normal mice, the mice in which chronic liver injury was induced (Sham), the mice receiving CTL-MBL and NGO-MBL transplantation. In each box plot, the center line indicates the median, the edges of the box indicate the 25th and 75th percentile, and the whiskers indicate the 10th and 90th percentile (n = 5). h Immunostaining of harvested CTL-MBLs and NGO-MBLs. ALB (green), HNF4α (red) and DAPI (blue). Scale bar, 100 µm. Picrosirius red staining (i) of livers in each group and quantification (j) of fibrotic area. Scale bar, 40 µm (n = 5). k qRT-PCR analysis of liver fibrosis-related genes in each group (n = 5). Serum ALT (l) and AST (m) levels of mice in each group, before and after transplantation (n = 5). Quantitative data were presented as a mean ± SD. Statistical differences between the groups were determined by unpaired, two-tailed student’s t test (c, e, f), Ordinary one-way ANOVA with post-hoc Tukey test (g, j, k) and two-way ANOVA with post-hoc Tukey test (l, m) (*p < 0.05, **p < 0.01, ***p < 0.001 versus CTL-MBL, ##p < 0.05, ###p < 0.001 versus Sham, ns; not statistically significant). Source data are provided as a Source Data file.CC BY · PubMed Central

Verification

Claims the paper makes

23 Valid · 2 Not valid · 16 Not checked · 105 Own results and interpretations

86 more claims · 4 with their cited sources checked

Create a free account to see all 146 claims and to verify the 7 references still open.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 37
  • The quote only partly states this claim. 2

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 69 references

Cited by

See all 53

Metadata

Authors
Kim, D.-H., Kim, M.-J., Kwak, S.-Y., Jeong, J., Choi, D., Choi, S. W., Ryu, J., & Kang, K.-S.
Affiliations
  • Seoul National University (KR)
  • Hanyang University (KR)
Corresponding author
Kang, Kyung-Sun
Venue
Nature Communications
Published
2023-02-13
Volume
14
Issue
1
Pages
801-801
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4320498301
Cited by
53
References
69
Citations by year
2026: 15 · 2025: 18 · 2024: 13 · 2023: 7
FWCI
14.14
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Research Foundation
  • Seoul National University
  • National Research Foundation of Korea
  • Ministry of Science and ICT, South Korea (22A0101L1‐11)
  • National Center for Inter-University Research Facilities, Seoul National University
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Materials Science › Biomaterials › Electrospun Nanofibers in Biomedical Applications
Keywords
nanographene oxide, decellularized liver scaffold, liver regeneration, matrix metalloproteinase inhibition, tissue inhibitors of metalloproteinases, M2 macrophage polarization, immunomodulation, enzyme resistance, allograft survival, liver failure, organ engineering, mechanical rigidity
MeSH terms
Animals, Extracellular Matrix, Graphite, Inflammation, Liver, Liver Regeneration, Oxides, Tissue Engineering, Mice, Tissue Scaffolds, Immunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation. https://app.cochat.ai/papers/10.1038/s41467-023-35941-2
The paper
Kim, D.-H., Kim, M.-J., Kwak, S.-Y., Jeong, J., Choi, D., Choi, S. W., Ryu, J., & Kang, K.-S. (2023). Bioengineered liver crosslinked with nano-graphene oxide enables efficient liver regeneration via MMP suppression and immunomodulation. Nature Communications. https://doi.org/10.1038/s41467-023-35941-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.